Healingpaper Co.,Ltd.

Established in 2012 and headquartered in Seoul, South Korea, Healingpaper Co. , Ltd. operates an innovative platform focusing on cosmetic surgery and skin treatment services, providing essential insights for patients and practitioners alike. Healingpaper Co.

, Ltd. is a company specializing in cosmetic surgery and skin treatments. Since its inception in Seoul, South Korea, it has secured a total of 7 deals, with the latest funding round being a Series C in February 2025, where the company raised KRW 42. 8 billion from various investors, including Korea Investment Partners.

The CEO is Aiden, although additional details about the founder's history are not available. Gangnam Unni primarily operates as a comprehensive information app focusing on cosmetic surgery and skin treatment services. The platform provides users with detailed insights into various procedures, including lifting, skin treatments, fat grafting, Botox, fillers, eye surgery, nose surgery, breast augmentation, facial contouring, dental care, hair removal, traditional medicine, and hair transplantation. The app serves as a valuable resource for potential patients, helping them navigate their options and make informed decisions regarding cosmetic enhancements.

It targets a wide array of users, from individuals considering aesthetic procedures to medical practitioners and clinics looking to connect with prospective clients. The service is primarily marketed towards the South Korean demographic, but the influence and reach may extend to international clients seeking credible information about cosmetic procedures. In 2024, Healingpaper Co. , Ltd.

generated revenue amounting to KRW 38,890,902. 70, with an EBITDA of KRW 9,825,282. 50. The company generates revenue through multiple streams, primarily focusing on partnerships with medical facilities and practitioners within the cosmetic surgery sector.

The platform allows clinics to register and promote their services to potential patients, likely operating on a partnership model. Revenue may be derived from subscription fees paid by medical facilities for enhanced visibility and promotional opportunities on the app, emphasizing a B2B arrangement that connects patients with trusted medical providers. In February 2025, Healingpaper Co. , Ltd.

raised KRW 42. 8 billion in Series C funding led by Korea Investment Partners, with participation from other investors. This funding will be utilized to expand the company's domestic and overseas businesses. While specific upcoming products or geographic regions targeted for expansion have not been detailed, the company’s growth strategy aims to enhance its platform and services in the cosmetic surgery sector.